IMVT
Immunovant, Inc.
NASDAQ · Healthcare · Biotechnology · US
$39.51
+1.00%Aug 18, 2026, 07:45 UTC
Immunovant, Inc. shares reached a new 52-week high of $43.89 during mid-day trading on Tuesday, last trading at $43.71 with a volume of 1,216,514 shares, after closing at $41.82.
Source:Aug 6, 2026, 00:00 UTC
Immunovant, Inc. reported its Q1 2026 financial results, with a GAAP net loss of $153.2 million and diluted EPS of -$0.75.
Source: